Chiron Real Estate’s SHOP pivot offers demographic-backed cash-flow growth and a potential re-rating, but the investment hinges on lease-up execution and disciplined asset recycling.
Overview
Chiron Real Estate Inc. (NYSE: XRN), formerly Global Medical REIT before its February 2026 rebrand, owns 4.6 million leasable square feet of outpatient healthcare facilities and is pivoting toward senior housing operating properties (SHOP). Outpatient triple-net leases provide recurring rent with a 4.4-year WALT and 2.1% average escalators; SHOP adds exposure to occupancy and rate growth, but also operating costs. Q2 2026 revenue was $39.75 million, up 8.1% year over year and 1.8% above consensus. Core FFO was $1.04 per share, down 8.8% year over year, while reported GAAP net income of $63.29 million included a $71.88 million gain on property sales. Management withdrew full-year 2026 guidance during the restructuring and cut the monthly dividend to $0.16, or $1.92 annualized, to retain capital; the Core FFO payout ratio is 34.3%. At $35.80, the shares trade at 11.4x forward P/FFO versus 14.5x for peers, with a 5.36% yield. **The key catalyst is SHOP lease-up, particularly Riviera toward more than 90% occupancy by H2 2028.** The balance sheet has no maturities until 2028, and near-term catalysts include asset dispositions and potential multiple convergence.